UniProt ID | PPM1D_HUMAN | |
---|---|---|
UniProt AC | O15297 | |
Protein Name | Protein phosphatase 1D | |
Gene Name | PPM1D | |
Organism | Homo sapiens (Human). | |
Sequence Length | 605 | |
Subcellular Localization | Nucleus . Cytoplasm, cytosol . | |
Protein Description | Involved in the negative regulation of p53 expression. [PubMed: 23242139 Required for the relief of p53-dependent checkpoint mediated cell cycle arrest. Binds to and dephosphorylates 'Ser-15' of TP53 and 'Ser-345' of CHEK1 which contributes to the functional inactivation of these proteins] | |
Protein Sequence | MAGLYSLGVSVFSDQGGRKYMEDVTQIVVEPEPTAEEKPSPRRSLSQPLPPRPSPAALPGGEVSGKGPAVAAREARDPLPDAGASPAPSRCCRRRSSVAFFAVCDGHGGREAAQFAREHLWGFIKKQKGFTSSEPAKVCAAIRKGFLACHLAMWKKLAEWPKTMTGLPSTSGTTASVVIIRGMKMYVAHVGDSGVVLGIQDDPKDDFVRAVEVTQDHKPELPKERERIEGLGGSVMNKSGVNRVVWKRPRLTHNGPVRRSTVIDQIPFLAVARALGDLWSYDFFSGEFVVSPEPDTSVHTLDPQKHKYIILGSDGLWNMIPPQDAISMCQDQEEKKYLMGEHGQSCAKMLVNRALGRWRQRMLRADNTSAIVICISPEVDNQGNFTNEDELYLNLTDSPSYNSQETCVMTPSPCSTPPVKSLEEDPWPRVNSKDHIPALVRSNAFSENFLEVSAEIARENVQGVVIPSKDPEPLEENCAKALTLRIHDSLNNSLPIGLVPTNSTNTVMDQKNLKMSTPGQMKAQEIERTPPTNFKRTLEESNSGPLMKKHRRNGLSRSSGAQPASLPTTSQRKNSVKLTMRRRLRGQKKIGNPLLHQHRKTVCVC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | GLYSLGVSVFSDQGG CCEECEEEEECCCCC | 18.69 | - | |
19 | Ubiquitination | FSDQGGRKYMEDVTQ ECCCCCCCCCEEEEE | 52.83 | 21890473 | |
25 | Phosphorylation | RKYMEDVTQIVVEPE CCCCEEEEEEEECCC | 25.54 | 26074081 | |
34 | Phosphorylation | IVVEPEPTAEEKPSP EEECCCCCCCCCCCC | 45.07 | 23663014 | |
40 | Phosphorylation | PTAEEKPSPRRSLSQ CCCCCCCCCCCCCCC | 41.95 | 30266825 | |
44 | Phosphorylation | EKPSPRRSLSQPLPP CCCCCCCCCCCCCCC | 33.38 | 30266825 | |
46 | Phosphorylation | PSPRRSLSQPLPPRP CCCCCCCCCCCCCCC | 30.88 | 30266825 | |
54 | Phosphorylation | QPLPPRPSPAALPGG CCCCCCCCCCCCCCC | 28.57 | 30266825 | |
64 | Phosphorylation | ALPGGEVSGKGPAVA CCCCCCCCCCCHHHH | 30.41 | 23312004 | |
66 | Acetylation | PGGEVSGKGPAVAAR CCCCCCCCCHHHHCH | 54.97 | 26051181 | |
85 | Phosphorylation | PLPDAGASPAPSRCC CCCCCCCCCCCHHHC | 22.22 | 23242139 | |
89 | Phosphorylation | AGASPAPSRCCRRRS CCCCCCCHHHCCCCC | 39.80 | 30266825 | |
96 | Phosphorylation | SRCCRRRSSVAFFAV HHHCCCCCCEEEEEE | 27.61 | 30266825 | |
97 | Phosphorylation | RCCRRRSSVAFFAVC HHCCCCCCEEEEEEE | 18.69 | 30266825 | |
162 | Acetylation | KKLAEWPKTMTGLPS HHHHHCCCHHCCCCC | 52.59 | 7491787 | |
184 | Acetylation | VVIIRGMKMYVAHVG EEEECCCEEEEEEEC | 29.88 | 7491797 | |
218 | Ubiquitination | VEVTQDHKPELPKER EEECCCCCCCCCHHH | 48.77 | - | |
223 | Ubiquitination | DHKPELPKERERIEG CCCCCCCHHHHHHCC | 80.28 | - | |
234 | Phosphorylation | RIEGLGGSVMNKSGV HHCCCCCCCCCCCCC | 19.18 | - | |
238 | Ubiquitination | LGGSVMNKSGVNRVV CCCCCCCCCCCCCEE | 30.41 | 21890473 | |
238 | Ubiquitination | LGGSVMNKSGVNRVV CCCCCCCCCCCCCEE | 30.41 | 21890473 | |
238 | Ubiquitination | LGGSVMNKSGVNRVV CCCCCCCCCCCCCEE | 30.41 | 21890473 | |
239 | Phosphorylation | GGSVMNKSGVNRVVW CCCCCCCCCCCCEEE | 42.86 | - | |
260 | Phosphorylation | HNGPVRRSTVIDQIP CCCCCCCCHHHHHHH | 19.23 | 27050516 | |
308 | Phosphorylation | LDPQKHKYIILGSDG CCCCCCEEEEECCCC | 7.91 | 22817900 | |
432 | Phosphorylation | DPWPRVNSKDHIPAL CCCCCCCCCCCHHHH | 36.28 | 25849741 | |
468 | Phosphorylation | VQGVVIPSKDPEPLE CCEEEECCCCCCCHH | 38.27 | 24719451 | |
469 | Ubiquitination | QGVVIPSKDPEPLEE CEEEECCCCCCCHHH | 72.45 | - | |
517 | Phosphorylation | QKNLKMSTPGQMKAQ CCCCCCCCCCCHHHH | 28.13 | - | |
529 | Phosphorylation | KAQEIERTPPTNFKR HHHHHCCCCCCCHHH | 22.34 | 25849741 | |
535 | Methylation | RTPPTNFKRTLEESN CCCCCCHHHHHHHCC | 46.68 | 115975533 | |
537 | O-linked_Glycosylation | PPTNFKRTLEESNSG CCCCHHHHHHHCCCC | 38.83 | 30379171 | |
537 | Phosphorylation | PPTNFKRTLEESNSG CCCCHHHHHHHCCCC | 38.83 | 25278378 | |
541 | Phosphorylation | FKRTLEESNSGPLMK HHHHHHHCCCCCCCH | 27.24 | 21712546 | |
543 | Phosphorylation | RTLEESNSGPLMKKH HHHHHCCCCCCCHHH | 51.58 | 25849741 | |
547 | Sulfoxidation | ESNSGPLMKKHRRNG HCCCCCCCHHHHHCC | 6.47 | 21406390 | |
558 | Phosphorylation | RRNGLSRSSGAQPAS HHCCCCCCCCCCCCC | 29.73 | 25849741 | |
559 | Phosphorylation | RNGLSRSSGAQPASL HCCCCCCCCCCCCCC | 36.72 | 25849741 | |
565 | Phosphorylation | SSGAQPASLPTTSQR CCCCCCCCCCCCCCC | 41.38 | - | |
568 | Phosphorylation | AQPASLPTTSQRKNS CCCCCCCCCCCCCCH | 44.35 | 22210691 | |
570 | Phosphorylation | PASLPTTSQRKNSVK CCCCCCCCCCCCHHH | 30.39 | - | |
589 | Ubiquitination | RRLRGQKKIGNPLLH HHHCCCCCCCCCCCC | 48.21 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PPM1D_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PPM1D_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MDM2_HUMAN | MDM2 | physical | 17936559 | |
H2AX_HUMAN | H2AFX | physical | 20101220 | |
H2AX_HUMAN | H2AFX | physical | 20460517 | |
H2AX_HUMAN | H2AFX | physical | 20118229 | |
RAD21_HUMAN | RAD21 | physical | 22145905 | |
KDM1A_HUMAN | KDM1A | physical | 25999347 | |
BEX2_HUMAN | BEX2 | physical | 25640309 | |
CASZ1_HUMAN | CASZ1 | physical | 25640309 | |
DIRA3_HUMAN | DIRAS3 | physical | 25640309 | |
DKK3_HUMAN | DKK3 | physical | 25640309 | |
ESIP1_HUMAN | EPSTI1 | physical | 25640309 | |
ERRFI_HUMAN | ERRFI1 | physical | 25640309 | |
GLCE_HUMAN | GLCE | physical | 25640309 | |
ITIH5_HUMAN | ITIH5 | physical | 25640309 | |
LYPD3_HUMAN | LYPD3 | physical | 25640309 | |
MRC2_HUMAN | MRC2 | physical | 25640309 | |
ARY2_HUMAN | NAT2 | physical | 25640309 | |
OSGI1_HUMAN | OSGIN1 | physical | 25640309 | |
RHBT2_HUMAN | RHOBTB2 | physical | 25640309 | |
NSD3_HUMAN | WHSC1L1 | physical | 25640309 | |
IMA1_HUMAN | KPNA2 | physical | 27880917 | |
IMA4_HUMAN | KPNA3 | physical | 27880917 | |
IMB1_HUMAN | KPNB1 | physical | 27880917 | |
NU153_HUMAN | NUP153 | physical | 27880917 | |
PSMD4_HUMAN | PSMD4 | physical | 27880917 | |
RBP2_HUMAN | RANBP2 | physical | 27880917 | |
JIP4_HUMAN | SPAG9 | physical | 27880917 | |
CHK2_HUMAN | CHEK2 | physical | 16311512 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-40, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY. |